These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6509453)

  • 61. The Kidney Invasion Test: an assay allowing macroscopic quantification of malignant invasion in vivo. Comparison between the microtubule inhibitor tubulozole and the podophyllotoxin congener etoposide (VP-16-213).
    Distelmans W; Van Ginckel R; Vanherck W; De Brabander M
    Invasion Metastasis; 1985; 5(3):170-84. PubMed ID: 3997412
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Etoposide in the treatment of multifocal eosinophilic granuloma.
    Urbano-Márquez A; Estruch R; Fernandez-Huerta JM; Montserrat E; Rozman C
    Cancer Treat Rep; 1985 Feb; 69(2):238-9. PubMed ID: 3971395
    [No Abstract]   [Full Text] [Related]  

  • 63. Lack of severe hypotension with VP-16-213 administered directly lv.
    Cavalli F; Sonntag RW; Ryssel HJ; Brunner KW
    Cancer Treat Rep; 1977 Oct; 61(7):1411. PubMed ID: 589604
    [No Abstract]   [Full Text] [Related]  

  • 64. Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26).
    Canal P; Bugat R; Chatelut E; Pinel MC; Houin G; Plusquellec Y; Carton M
    Eur J Cancer Clin Oncol; 1989 May; 25(5):815-20. PubMed ID: 2737218
    [TBL] [Abstract][Full Text] [Related]  

  • 65. VP16-213 (etoposide). A critical review of its activity.
    Cavalli F
    Cancer Chemother Pharmacol; 1982; 7(2-3):81-5. PubMed ID: 7044594
    [No Abstract]   [Full Text] [Related]  

  • 66. Etoposide: a new anti-cancer agent.
    Arnold AM; Whitehouse JM
    Lancet; 1981 Oct; 2(8252):912-5. PubMed ID: 6117692
    [No Abstract]   [Full Text] [Related]  

  • 67. Etoposide single-agent chemotherapy for solid tumors.
    Jungi WF
    Cancer Treat Rev; 1982 Jun; 9 Suppl():31-7. PubMed ID: 6290055
    [No Abstract]   [Full Text] [Related]  

  • 68. Pharmacodynamics and long-term toxicity of etoposide.
    Kobayashi K; Ratain MJ
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S64-8. PubMed ID: 8070030
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Etoposide-induced hepatic injury: a potential complication of high-dose therapy.
    Johnson DH; Greco FA; Wolff SN
    Cancer Treat Rep; 1983 Nov; 67(11):1023-4. PubMed ID: 6315228
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations.
    Stewart CF
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S76-83. PubMed ID: 8070032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of a water-soluble and a water-insoluble podophyllotoxin derivative in murine neoplasms.
    Kreis W; Soricelli A
    J Cancer Res Clin Oncol; 1979; 95(3):233-7. PubMed ID: 528564
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Review of etoposide single-agent activity.
    Schmoll H
    Cancer Treat Rev; 1982 Jun; 9 Suppl():21-30. PubMed ID: 6751532
    [No Abstract]   [Full Text] [Related]  

  • 73. New anticancer drug class.
    Fuerst ML
    JAMA; 1983 Mar; 249(12):1539, 1543. PubMed ID: 6827733
    [No Abstract]   [Full Text] [Related]  

  • 74. New perspectives on the toxicity of etoposide.
    Kobayashi K; Ratain MJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):78-83. PubMed ID: 1492230
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Etoposide for therapy-resistant testicular tumors.
    Varini M; Cavalli F
    Cancer Treat Rev; 1982 Jun; 9 Suppl():73-8. PubMed ID: 7127337
    [No Abstract]   [Full Text] [Related]  

  • 76. Etoposide in the treatment of refractory breast cancer.
    Höffken K
    Cancer Treat Rev; 1982 Jun; 9 Suppl():63-6. PubMed ID: 7127336
    [No Abstract]   [Full Text] [Related]  

  • 77. Multifocal eosinophilic granuloma. Response of a patient to etoposide.
    Hocking WG; Swanson M
    Cancer; 1986 Aug; 58(4):840-2. PubMed ID: 3719552
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Oral pathology during chemotherapy for solid tumors].
    D'Errico P; Guerra M; Bertoli A; Tullio A
    G Stomatol Ortognatodonzia; 1987; 6(1):15-7. PubMed ID: 3482454
    [No Abstract]   [Full Text] [Related]  

  • 79. Chronic myelomonocytic leukaemia: a case report.
    Gétaz EP; Staples WG
    S Afr Med J; 1977 Jun; 51(23):852-3. PubMed ID: 267330
    [No Abstract]   [Full Text] [Related]  

  • 80. Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease.
    Scher HI; Sternberg C; Heston WD; Watson RC; Niedzwiecki D; Smart T; Hollander P; Yagoda A
    Cancer Chemother Pharmacol; 1986; 18(1):24-6. PubMed ID: 3757155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.